Skip to main content
. 2022 Jul 15;97(5):566–574. doi: 10.1016/j.abd.2021.11.002

Table 2.

The most common adverse events in patients treated with secukinumab.

Adverse event n (%)
Candida infections 23 (10.4)
Vaginal 9 (3.93)
Intertriginous 9 (3.93)
Oropharyngeal 4 (1.75)
Onychomycosis 3 (1.31)
Erosio interdigitalis blastomycetica 3 (1.31)
Fatigue 17 (7.42)
Nasopharyngitis 16 (6.99)
Paradoxical arthritis 13 (5.68)
Bronchitis 4 (1.75)
Arthralgia 4 (1.75)
Pruritus 3 (1.31)
Increase in weight 3 (1.31)